Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Hi-Tech Pharmacal Co Inc HITK

Healthcare Drug Manufacturers - Specialty & Generic

Recent & Breaking News (NDAQ:HITK)

Keller Rohrback L.L.P. Announces Investigation Regarding Weight-Loss and Workout Supplements Containing Potentially Dangerous Amounts of Amphetamine-Like Chemical BMPEA

Business Wire April 8, 2015

Akorn Completes Acquisition of Hi-Tech Pharmacal

Business Wire April 17, 2014

Repligen Corporation Set to Join the S&P SmallCap 600

PR Newswire April 15, 2014

Akorn Receives FTC Clearance for Hi-Tech Pharmacal Acquisition

Business Wire April 14, 2014

Hi-Tech Pharmacal Reports Sales of $59.9 Million for the Third Quarter Ended January 31, 2014

Business Wire March 11, 2014

Hi-Tech Pharmacal Receives Final Approval for Bromfenac Ophthalmic Solution, 0.09% (Once-A-Day)

Business Wire January 23, 2014

Hi-Tech Pharmacal Announces Settlement Regarding Texas Pricing Investigation

Business Wire December 26, 2013

Hi-Tech Pharmacal Reports Sales of $58.6 million for the Second Quarter Ended October 31, 2013

Business Wire December 10, 2013

Acquisition of Hi-Tech Pharmacal Co., Inc. (HITK) by Akorn, Inc. (AKRX) May Be Detrimental to the Interests of Hi-Tech Pharmacal Co., Inc. Shareholders

PR Newswire September 25, 2013

HI-TECH PHARMACAL SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Launches an Investigation of Hi-Tech Pharmacal Co., Inc. (HITK) Over the Proposed Sale of the Company to Akorn, Inc. (AKRX)

Business Wire September 13, 2013

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Hi-Tech Pharmacal Co. in Connection With the Sale of the Company to Akorn, Inc. -- HITK

Globe Newswire September 12, 2013

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Hi-Tech Pharmacal Co.

Business Wire September 11, 2013

HI-TECH PHARMACAL CO. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Hi-Tech Pharmacal Co. in Connection With the Sale of the Company

Marketwired September 9, 2013

Hi-Tech Pharmacal Reports Sales of $50.5 Million for the First Quarter Ended July 31, 2013

Business Wire September 9, 2013

Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 9, 2013

Business Wire September 5, 2013

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Hi-Tech Pharmacal Co.

PR Newswire September 4, 2013

HI-TECH PHARMACAL CO. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Hi-Tech Pharmacal Co. in Connection With the Sale of the Company -- HITK

Globe Newswire September 4, 2013

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Hi-Tech Pharmacal Co.

Business Wire September 3, 2013

InvestorsGuru.com 39 Filtered Mid-Day Market Movers Recap

Investors Guru September 1, 2013

HI-TECH PHARMACAL CO. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Hi-Tech Pharmacal Co.

PR Newswire August 30, 2013